Page last updated: 2024-08-21

alpha-aminopyridine and Cerebral Small Vessel Diseases

alpha-aminopyridine has been researched along with Cerebral Small Vessel Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Dabertrand, F; Fontaine, JT; Joutel, A; Rosehart, AC	1

Other Studies

1 other study(ies) available for alpha-aminopyridine and Cerebral Small Vessel Diseases

Article	Year
HB-EGF depolarizes hippocampal arterioles to restore myogenic tone in a genetic model of small vessel disease. Mechanisms of ageing and development, 2020, Volume: 192 Topics: Aminopyridines; Animals; Arterioles; Cerebral Small Vessel Diseases; Dementia, Vascular; Heparin-binding EGF-like Growth Factor; Hippocampus; Membrane Potentials; Membrane Transport Modulators; Mice; Microcirculation; Models, Genetic; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Potassium Channels, Voltage-Gated; Vasoconstriction	2020

Article

Year

HB-EGF depolarizes hippocampal arterioles to restore myogenic tone in a genetic model of small vessel disease.

Mechanisms of ageing and development, 2020, Volume: 192

Topics: Aminopyridines; Animals; Arterioles; Cerebral Small Vessel Diseases; Dementia, Vascular; Heparin-binding EGF-like Growth Factor; Hippocampus; Membrane Potentials; Membrane Transport Modulators; Mice; Microcirculation; Models, Genetic; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Potassium Channels, Voltage-Gated; Vasoconstriction

2020